MJ

M. Jaione Maiz

Investor | Business Development | Kauffman Fellow

Redwood City, California

Overview

Work Experience

  • Principal, Venture Capital

    2021 - 2024

    Anzu Partners is an investment firm that focuses on breakthrough industrial and life sciences technology companies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. https://www.anzupartners.com/

  • Board Observer

    2023 - 2024

  • Board Observer

    2023 - 2024

  • Board Observer

    2022 - 2024

  • Board Observer

    2022 - 2024

  • Interim Chief Business Officer

    2022 - 2023

    Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work deeply with our company NTx to lead the company’s commercial transformation including go-to-market strategy, commercial operations, and key partnerships. — Nature's Toolbox, Inc. (NTx) is a next-generation biomanufacturing company located in Rio Rancho, New Mexico. NTx's proprietary cell-free, continuous-flow, fully recombinant, in vitro systems utilize hollow fiber bioreactors to effectively and cost-efficiently produce biologics, including mRNA and proteins, to support the growing demand for next generation vaccines and therapeutics. NTx’s biomanufacturing solutions easily scale to meet fluctuating demand, and can operate using NTx's proprietary critical raw materials (including enzymes), to avoid fragile supply chain constraints in times of high market need. For more information, please visit: https://www.ntxbio.com

  • Board Observer

    2021 - 2024

  • Interim Chief Business Officer

    2022 - 2022

    Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work deeply with our company BioSkryb to lead the commercial team during a critical time of new partnerships and product launch. — BioSkryb has industry leading genome amplification technology that enables true comprehensive multi-omic analysis, at high resolution, in single cells. For more information, please visit: https://www.bioskryb.com/

  • Board Observer

    2021 - 2024

  • Business Development

    2023 - 2023

    Active portfolio company support is an important part of our investor mandate at Anzu Partners. I had the opportunity to work with our company Terapore to support business development. — Terapore is developing next-generation precise nanofiltration solutions for bioprocessing and beyond! For more information, please visit: https://www.terapore.com/

  • Director, Business Development

    2018 - 2021

    Zymergen is a science & material innovation company rethinking biology and reimagining the world. We partner with nature to create the products of tomorrow.

  • Business Development Manager

    2015 - 2017

Relevant Websites